GO
Loading...

Baxter International Inc

More

  • Midday Glance: Medical Devices companies Wednesday, 9 Apr 2014 | 1:15 PM ET

    Allergan rose $1.95 or 1.7 percent, to $119.86. Baxter International Inc. rose$. 62 or. 9 percent, to $72.92. Boston Scientific Corp. rose$. 47 or 3.6 percent, to $13.38.

  • Midday Glance: Pharmaceuticals companies Wednesday, 9 Apr 2014 | 1:15 PM ET

    Baxter International Inc. rose$. 62 or. 9 percent, to $72.92. Bristol-Myers Squibb Co. rose$. 87 or 1.8 percent, to $49.93. Hospira rose$. 52 or 1.2 percent, to $44.04.

  • Early Glance: Pharmaceuticals companies Tuesday, 8 Apr 2014 | 10:43 AM ET

    Baxter International Inc. rose$. 24 or. 3 percent, to $72.73. Johnson& Johnson rose$. 04 or percent, to $97.93. Eli Lilly& Co. rose$. 04 or. 1 percent, to $58.66.

  • Early Glance: Medical Devices companies Tuesday, 8 Apr 2014 | 10:43 AM ET

    Allergan fell$. 65 or. 5 percent, to $120.13. Baxter International Inc. rose$. 24 or. 3 percent, to $72.73. Boston Scientific Corp. fell$. 17 or 1.3 percent, to $13.05.

  • Final Glance: Medical Devices companies Monday, 7 Apr 2014 | 6:01 PM ET

    Allergan fell $3.35 or 2.7 percent, to $120.77. Baxter International Inc. fell$. 44 or. 6 percent, to $72.49. Boston Scientific Corp. fell$. 28 or 2.1 percent, to $13.22.

  • Final Glance: Pharmaceuticals companies Monday, 7 Apr 2014 | 6:01 PM ET

    Baxter International Inc. fell$. 44 or. 6 percent, to $72.49. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $50.28. Hospira fell$. 37 or. 9 percent, to $43.01.

  • Midday Glance: Pharmaceuticals companies Monday, 7 Apr 2014 | 1:50 PM ET

    Baxter International Inc. rose$. 06 or. 1 percent, to $72.99. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $50.28. Hospira fell$. 55 or 1.3 percent, to $42.83.

  • Midday Glance: Medical Devices companies Monday, 7 Apr 2014 | 1:50 PM ET

    Allergan fell $3.31 or 2.7 percent, to $120.81. Baxter International Inc. rose$. 06 or. 1 percent, to $72.99. Boston Scientific Corp. fell$. 15 or 1.1 percent, to $13.35.

  • Final Glance: Pharmaceuticals companies Friday, 4 Apr 2014 | 6:19 PM ET

    Baxter International Inc. fell$. 46 or. 6 percent, to $72.93. Bristol-Myers Squibb Co. fell$. 98 or 1.9 percent, to $49.89. Hospira fell $1.17 or 2.6 percent, to $43.38.

  • Final Glance: Medical Devices companies Friday, 4 Apr 2014 | 6:19 PM ET

    Allergan fell $1.26 or 1.0 percent, to $124.12. Baxter International Inc. fell$. 46 or. 6 percent, to $72.93. Boston Scientific Corp. fell$. 27 or 2.0 percent, to $13.50.

  • April 4- Halozyme Therapeutics Inc halted a mid-stage trial testing an advanced version of its flagship drug delivery technology in patients with pancreatic cancer, sending its shares tumbling 32 percent.

  • Midday Glance: Pharmaceuticals companies Friday, 4 Apr 2014 | 1:20 PM ET

    Baxter International Inc. rose$. 26 or. 3 percent, to $73.64. Bristol-Myers Squibb Co. fell$. 08 or. 2 percent, to $50.79. Hospira fell $1.15 or 2.6 percent, to $43.40.

  • Midday Glance: Medical Devices companies Friday, 4 Apr 2014 | 1:20 PM ET

    Allergan fell$. 24 or. 2 percent, to $125.14. Baxter International Inc. rose$. 26 or. 3 percent, to $73.64. Boston Scientific Corp. fell$. 21 or 1.5 percent, to $13.57.

  • Early Glance: Medical Devices companies Friday, 4 Apr 2014 | 10:57 AM ET

    Allergan rose$. 66 or. 5 percent, to $126.04. Baxter International Inc. rose$. 24 or. 3 percent, to $73.63. Boston Scientific Corp. rose$. 08 or. 6 percent, to $13.85.

  • Early Glance: Pharmaceuticals companies Friday, 4 Apr 2014 | 10:57 AM ET

    Baxter International Inc. rose$. 24 or. 3 percent, to $73.63. Bristol-Myers Squibb Co. rose$. 60 or 1.2 percent, to $51.47. Hospira fell$. 50 or 1.1 percent, to $44.05.

  • March 28- Biogen Idec Inc has won U.S. approval for its long-acting hemophilia B treatment Alprolix, the U.S. Food and Drug Administration said on Friday. It affects about 4,000 people in the United States and 25,000 worldwide.

  • March 27- Baxter International Inc said it would spin off its biotechnology operations into a publicly traded company by the middle of next year, leaving behind its core medical technology business.

  • March 27- Healthcare company Baxter International Inc said on Thursday it would separate into two companies, one that focuses on biotechnology and the other devoted to medical equipment. The company said its biotech business had 2013 revenue of $6 billion while medical products and equipment sales were $9 billion.

  • LONDON/ FRANKFURT, Feb 12- France's Danone is weighing a sale of its tube feeding products business which could fetch over 3 billion euros as it expands its dairy business in higher-growth emerging markets, three people familiar with the deal said.

  • U.S. hospitals hit with shortage of intravenous saline Tuesday, 28 Jan 2014 | 5:32 PM ET

    Jan 28- The U.S. Food and Drug Administration said on Tuesday it is working with the three manufacturers of intravenous saline solutions commonly used to hydrate hospital patients to address a shortage caused by a spike in demand.

Most Popular Video

Wednesday, 16 Apr 2014 | 11:56 AM ET

Art Cashin, UBS director of floor operations, explains what played into yesterday's market reversal and tells what sectors are back in favor today.

Wednesday, 16 Apr 2014 | 12:25 PM ET

CNBC's Steve Liesman provides insight into the highlights of Fed Chair Janet Yellen's comments at The Economic Club of New York.

Wednesday, 16 Apr 2014 | 12:15 PM ET

Josh Spencer, T. Rowe Price portfolio manager, encourages investors to get some guts and buy into growth stocks like Tesla and Amazon. He shares his opinions on some of the old tech names.